Home › Funds › Viking Global Investors › BMRN
Viking Global Investors position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Latest position (Q2 2026)7.62M sh
Reported value held$435.82M
Portfolio Weight1.26%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 2.87M | $253.56M | New |
| Q1 2022 | 3.75M | $289.31M | Add |
| Q2 2022 | 5.05M | $418.71M | Add |
| Q3 2022 | 5.10M | $432.26M | Add |
| Q4 2022 | 5.27M | $545.77M | Add |
| Q1 2023 | 2.17M | $210.88M | Reduce |
| Q2 2023 | 4.16M | $360.31M | Add |
| Q3 2023 | 4.22M | $372.98M | Add |
| Q4 2023 | 4.89M | $471.44M | Add |
| Q1 2024 | 6.42M | $560.40M | Add |
| Q2 2024 | 7.06M | $581.54M | Add |
| Q3 2024 | 9.75M | $685.56M | Add |
| Q4 2024 | 10.51M | $690.86M | Add |
| Q1 2025 | 10.80M | $763.46M | Add |
| Q2 2025 | 12.29M | $675.50M | Add |
| Q3 2025 | 8.32M | $450.73M | Reduce |
| Q4 2025 | 6.04M | $358.78M | Reduce |
| Q1 2026 | 7.06M | $398.94M | Add |
| Q2 2026 | 7.62M | $435.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMRN
- Vanguard Group 18.13M sh · $1.08B · Q4 2025
- Dodge & Cox 14.84M sh · $849.43M · Q2 2026
- Norges Bank Investment Management 8.21M sh · $469.66M · Q2 2026
- AQR Capital Management 5.70M sh · $322.54M · Q2 2026
- Fidelity Management & Research (FMR) 4.82M sh · $275.97M · Q2 2026
- Geode Capital Management 3.91M sh · $223.89M · Q2 2026
- Capital Research Global Investors 3.50M sh · $200.52M · Q2 2026
- Millennium Management 2.11M sh · $120.95M · Q2 2026
- Charles Schwab Investment Management 1.62M sh · $92.47M · Q2 2026
- Northern Trust Corp 1.56M sh · $89.15M · Q2 2026
- Citadel Advisors 1.40M sh · $80.28M · Q2 2026